欢迎来到天天文库
浏览记录
ID:46796730
大小:86.50 KB
页数:12页
时间:2019-11-27
《盆腔炎患者应用盐酸左氧氟沙星的临床疗效观察》由会员上传分享,免费在线阅读,更多相关内容在工程资料-天天文库。
1、盆腔炎患者应用盐酸左氧氟沙星的临床疗效观察【摘要】目的:探讨盆腔炎患者应用盐酸左氧氟沙星的临床优势。方法:选取2014年3月-2015年3月笔者所在医院收治的160例盆腔炎患者为研究对象,按照随机数字表法将其均分为试验组和对照组,每组80例。试验组患者给予盐酸左氧氟沙星治疗,对照组患者给予氧氟沙星治疗。对比两组患者治疗结束后的临床疗效、治疗前后C-反应蛋白(C-reactiveprotein,CRP).白细胞计数(whitebloodcellcount,WBC)水平的变化情况、治疗期间不良反应发生情况以及随访6个月的复发情况。结果:试验组患者治疗总有效率98.75%显著高于
2、对照组的90.00%,差异有统计学意义(P〈0.05);治疗后,两组患者CRP与WBC水平均明显低于同组治疗前,差异均有统计学意义(P<0.05);治疗后,试验组患者CRP与WBC水平均明显低于对照组,差异均有统计学意义(P〈0.05);试验组患者治疗期间不良反应总发生率7.50%显著低于对照组的25.00%,差异有统计学意义(P〈0・05);试验组随访期间的复发率5.00%明显低于对照组的15.00%,差异有统计学意义(P3、氟沙星;氧氟沙星;疗效;不良反应中图分类号R711.33文献标识码B文章编号1674-6805(2016)21-0013-03IAbstract1Objective:ToexploretheclinicadvantagesofLevofloxacinHydrochloonpatientswithpelvicinflammatorydisease・Method:OnehundredandsixtycasesofpatientswithpelvicinflammatorydiseaseadmittedtoourhospitalfromMarch2014toMarch2015we4、reselectedastheobjectsandrandomlydividedintotheexperimentgroupandthecontrolgroup,theexperimentgroupwastreatedbyLevofloxacinHydrochlo,whilethecontrolgroupwastreatedbyOfloxacin,theclinicaleffects,CRP,thelevelsofWBC,theadversereactionsandtherecurrenceratewerecompared・Result:Thetotaleffectiver5、atefortheexperimentgroupwas98.75%,higherthan90.00%ofthecontrolgroup,thedifferencewasstatisticallysignificant(P<0.05)・TheCRP,thelevelsofWBCinthetwogroupsaftertreatmentwerelowerthanbeforetreatment,thedifferencesweresta/tisticallysignificant(P<0.05)・TheCRP,levelsofWBCintheexperimentgroupafter6、treatmentwerelowerthanthoseofthecontrolgroup,thedifferenceswerestatisticallysignificant(P〈0.05)・Therateofadversereactionsoftheexperimentgroupwere7.50%,lowerthan25.00%ofthecontrolgroup,thedifferencewasstatisticallysignificant(P〈0.05).Therecurrencerateoftheexperimentgroupwas5.00%,lowerthan157、.00%ofthecontrolgroup,thedifferencewasstatisticallysignificant(P<0.05)・Conclusion:LevofloxacinHydrochlohasbetterclinicaleffectsonthepatientswithpelvicinflammatorydisease,withmoreobviousanti-inflammatoryeffect,noadversereactions,lowrecurrencerate,itcanbeusedasa
3、氟沙星;氧氟沙星;疗效;不良反应中图分类号R711.33文献标识码B文章编号1674-6805(2016)21-0013-03IAbstract1Objective:ToexploretheclinicadvantagesofLevofloxacinHydrochloonpatientswithpelvicinflammatorydisease・Method:OnehundredandsixtycasesofpatientswithpelvicinflammatorydiseaseadmittedtoourhospitalfromMarch2014toMarch2015we
4、reselectedastheobjectsandrandomlydividedintotheexperimentgroupandthecontrolgroup,theexperimentgroupwastreatedbyLevofloxacinHydrochlo,whilethecontrolgroupwastreatedbyOfloxacin,theclinicaleffects,CRP,thelevelsofWBC,theadversereactionsandtherecurrenceratewerecompared・Result:Thetotaleffectiver
5、atefortheexperimentgroupwas98.75%,higherthan90.00%ofthecontrolgroup,thedifferencewasstatisticallysignificant(P<0.05)・TheCRP,thelevelsofWBCinthetwogroupsaftertreatmentwerelowerthanbeforetreatment,thedifferencesweresta/tisticallysignificant(P<0.05)・TheCRP,levelsofWBCintheexperimentgroupafter
6、treatmentwerelowerthanthoseofthecontrolgroup,thedifferenceswerestatisticallysignificant(P〈0.05)・Therateofadversereactionsoftheexperimentgroupwere7.50%,lowerthan25.00%ofthecontrolgroup,thedifferencewasstatisticallysignificant(P〈0.05).Therecurrencerateoftheexperimentgroupwas5.00%,lowerthan15
7、.00%ofthecontrolgroup,thedifferencewasstatisticallysignificant(P<0.05)・Conclusion:LevofloxacinHydrochlohasbetterclinicaleffectsonthepatientswithpelvicinflammatorydisease,withmoreobviousanti-inflammatoryeffect,noadversereactions,lowrecurrencerate,itcanbeusedasa
此文档下载收益归作者所有